Abbott Laboratories ROA 2010-2025 | ABT

Current and historical return on assets (ROA) values for Abbott Laboratories (ABT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Abbott Laboratories ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-06-30 $13.98B $0.00B 23.57%
2025-03-31 $13.50B $81.45B 17.41%
2024-12-31 $13.40B $81.41B 17.79%
2024-09-30 $5.77B $74.36B 7.87%
2024-06-30 $5.56B $73.02B 7.64%
2024-03-31 $5.63B $72.47B 7.74%
2023-12-31 $5.72B $73.21B 7.83%
2023-09-30 $5.16B $72.09B 7.03%
2023-06-30 $5.16B $73.35B 7.01%
2023-03-31 $5.80B $73.79B 7.86%
2022-12-31 $6.93B $74.44B 9.39%
2022-09-30 $7.89B $72.80B 10.65%
2022-06-30 $8.55B $74.20B 11.51%
2022-03-31 $7.73B $74.01B 10.43%
2021-12-31 $7.07B $75.20B 9.59%
2021-09-30 $7.24B $73.80B 9.91%
2021-06-30 $6.38B $73.27B 8.87%
2021-03-31 $5.72B $72.79B 8.09%
2020-12-31 $4.50B $72.55B 6.49%
2020-09-30 $3.38B $69.04B 4.96%
2020-06-30 $3.11B $68.78B 4.57%
2020-03-31 $3.58B $66.78B 5.27%
2019-12-31 $3.69B $67.89B 5.41%
2019-09-30 $3.29B $68.54B 4.85%
2019-06-30 $2.90B $68.43B 4.21%
2019-03-31 $2.62B $67.61B 3.82%
2018-12-31 $2.37B $67.17B 3.41%
2018-09-30 $0.89B $71.64B 1.23%
2018-06-30 $0.93B $68.42B 1.29%
2018-03-31 $0.48B $70.91B 0.66%
2017-12-31 $0.48B $76.25B 0.66%
2017-09-30 $2.10B $72.25B 3.15%
2017-06-30 $1.17B $71.15B 2.00%
2017-03-31 $1.50B $70.89B 2.96%
2016-12-31 $1.40B $52.67B 3.26%
2016-09-30 $1.37B $39.50B 3.42%
2016-06-30 $2.28B $39.83B 5.61%
2016-03-31 $2.45B $39.64B 5.87%
2015-12-31 $4.42B $41.25B 10.40%
2015-09-30 $4.56B $41.73B 10.72%
2015-06-30 $4.52B $44.13B 10.57%
2015-03-31 $4.20B $43.10B 9.99%
2014-12-31 $2.28B $41.21B 5.48%
2014-09-30 $1.97B $42.51B 4.67%
2014-06-30 $2.40B $41.48B 5.63%
2014-03-31 $2.41B $41.66B 5.61%
2013-12-31 $2.58B $42.95B 5.97%
2013-09-30 $3.04B $44.13B 6.17%
2013-06-30 $4.02B $42.90B 7.43%
2013-03-31 $5.27B $42.69B 8.96%
2012-12-31 $5.96B $67.24B 9.36%
2012-09-30 $6.53B $63.26B 10.54%
2012-06-30 $4.89B $61.86B 8.01%
2012-03-31 $5.11B $62.42B 8.36%
2011-12-31 $4.73B $60.28B 7.77%
2011-09-30 $4.55B $59.63B 7.47%
2011-06-30 $5.14B $62.00B 8.51%
2011-03-31 $4.49B $61.65B 7.71%
2010-12-31 $4.63B $60.57B 8.24%
2010-09-30 $4.73B $57.37B 8.72%
2010-06-30 $5.31B $53.38B 10.16%
2010-03-31 $5.31B $53.36B 10.44%
2009-12-31 $5.75B $52.58B 11.76%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $209.668B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $154.824B 38.76
Stryker (SYK) United States $148.439B 31.04
EssilorLuxottica (ESLOY) France $131.494B 0.00
Medtronic (MDT) Ireland $114.826B 16.28
Lonza Group Ag (LZAGY) Switzerland $49.743B 0.00
Haleon (HLN) United Kingdom $43.081B 24.59
ResMed (RMD) United States $37.598B 28.24
GE HealthCare Technologies (GEHC) United States $34.909B 16.57
Agilent Technologies (A) United States $33.054B 21.55
Terumo (TRUMY) Japan $24.345B 31.62
Koninklijke Philips (PHG) Netherlands $23.697B 16.63
Insulet (PODD) United States $19.948B 78.30
Zimmer Biomet Holdings (ZBH) United States $18.776B 12.06
Baxter (BAX) United States $14.312B 10.69
Smith & Nephew SNATS (SNN) United Kingdom $13.087B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.794B 23.64
Lantheus Holdings (LNTH) United States $5.092B 12.85
Perrigo (PRGO) Ireland $3.733B 9.46
Prestige Consumer Healthcare (PBH) United States $3.713B 16.58
Haemonetics (HAE) United States $3.529B 16.07
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.347B 27.82
ICU Medical (ICUI) United States $3.070B 22.64
LeMaitre Vascular (LMAT) United States $1.855B 41.47
QuidelOrtho (QDEL) United States $1.804B 12.41
AtriCure (ATRC) United States $1.473B 0.00
Acuren (TIC) United States $1.444B 0.00
AdaptHealth (AHCO) United States $1.242B 12.60
Green Thumb Industries (GTBIF) United States $1.207B 27.14
Phibro Animal Health (PAHC) United States $1.205B 15.40
Neogen (NEOG) United States $1.055B 13.50
BioLife Solutions (BLFS) United States $1.025B 0.00
InMode (INMD) Israel $0.891B 8.98
Kestra Medical Technologies (KMTS) United States $0.845B 0.00
Curaleaf Holdings (CURLF) Canada $0.674B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.639B 0.00
Owens & Minor (OMI) United States $0.617B 5.12
Tilray Brands (TLRY) Canada $0.615B 0.00
Evolus (EOLS) United States $0.602B 0.00
CeriBell (CBLL) United States $0.565B 0.00
Valneva SE (VALN) France $0.553B 0.00
Surmodics (SRDX) United States $0.438B 0.00
SNDL (SNDL) Canada $0.410B 0.00
Capricor Therapeutics (CAPR) United States $0.327B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.89
Sanuwave Health (SNWV) United States $0.321B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.275B 0.00
Cresco Labs (CRLBF) United States $0.270B 0.00
Viemed Healthcare (VMD) United States $0.264B 22.23
Cerus (CERS) United States $0.262B 0.00
Aurora Cannabis (ACB) Canada $0.256B 75.83
OraSure Technologies (OSUR) United States $0.245B 0.00
Sanara MedTech (SMTI) United States $0.244B 0.00
ZimVie (ZIMV) United States $0.241B 10.96
Biote (BTMD) United States $0.228B 6.42
Brainsway (BWAY) Israel $0.219B 58.05
Verano Holdings (VRNOF) United States $0.204B 0.00
Canopy Growth (CGC) Canada $0.204B 0.00
Omeros (OMER) United States $0.204B 0.00
High Tide (HITI) Canada $0.203B 0.00
Organigram Global (OGI) Canada $0.196B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.82
TriSalus Life Sciences (TLSI) United States $0.179B 0.00
Exagen (XGN) United States $0.153B 0.00
Vireo Growth (VREOF) United States $0.150B 0.00
FitLife Brands (FTLF) United States $0.125B 15.33
TerrAscend (TSNDF) Canada $0.107B 0.00
Jin Medical (ZJYL) China $0.101B 0.00
Fonar (FONR) United States $0.099B 12.74
MacroGenics (MGNX) United States $0.097B 0.00
Veru (VERU) United States $0.090B 0.00
Quipt Home Medical (QIPT) United States $0.090B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Apyx Medical (APYX) United States $0.086B 0.00
Jushi Holdings (JUSHF) United States $0.081B 0.00
Zynex (ZYXI) United States $0.071B 0.00
Agape ATP (ATPC) $0.071B 0.00
InterCure (INCR) Israel $0.068B 0.00
Cytosorbents (CTSO) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Safety Shot (SHOT) United States $0.052B 0.00
United-Guardian (UG) United States $0.042B 14.54
Nephros (NEPH) United States $0.038B 51.14
Modular Medical (MODD) United States $0.038B 0.00
Rockwell Medical (RMTI) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00